Ru-Rong Ji Selected Research

Ru-Rong Ji Research Topics

Disease

107	Pain (Aches) 03/2024 - 01/2002
61	Hyperalgesia 03/2024 - 09/2002
60	Neuralgia (Stump Neuralgia) 10/2023 - 04/2002
31	Inflammation (Inflammations) 03/2024 - 01/2002
28	Chronic Pain 03/2024 - 07/2009
26	Hypersensitivity (Allergy) 12/2020 - 01/2002
19	Neoplasms (Cancer) 01/2023 - 05/2008
12	Neuroinflammatory Diseases 11/2022 - 07/2009
8	Postoperative Pain 12/2022 - 01/2009
7	Cancer Pain 01/2023 - 09/2009
6	Peripheral Nerve Injuries 01/2024 - 09/2003
5	Peripheral Nervous System Diseases (PNS Diseases) 03/2024 - 01/2019
5	Acute Pain 12/2023 - 12/2011
5	Pruritus (Itching) 01/2023 - 11/2010
4	Bites and Stings (Sting) 01/2024 - 01/2021
4	Bone Neoplasms (Bone Cancer) 01/2021 - 05/2015
4	Edema (Dropsy) 01/2021 - 07/2006
3	Allergic Contact Dermatitis 01/2023 - 04/2016
3	Infections 11/2022 - 10/2020
3	Arthritis (Polyarthritis) 01/2021 - 09/2011
3	Diabetic Neuropathies (Diabetic Neuropathy) 01/2019 - 08/2011
2	Hypothermia 01/2023 - 01/2021
2	Virus Diseases (Viral Diseases) 01/2023 - 08/2011
2	Osteoarthritis 01/2023 - 01/2022
2	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2021
2	Sepsis (Septicemia) 01/2023 - 01/2021

Drug/Important Bio-Agent (IBA)

26	CytokinesIBA 01/2024 - 07/2006
16	Analgesics (Analgesic Drugs)IBA 01/2024 - 09/2002
15	Opioid Analgesics (Opioids)IBA 10/2021 - 09/2002
13	ChemokinesIBA 12/2020 - 07/2009
13	Formaldehyde (Formol)FDA Link 01/2020 - 03/2006
12	LipidsIBA 01/2023 - 05/2010
12	Capsaicin (Zostrix)FDA Link 01/2021 - 09/2004
11	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 11/2016
10	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 12/2022 - 09/2002
10	p38 Mitogen-Activated Protein KinasesIBA 01/2018 - 09/2002
9	Proteins (Proteins, Gene)FDA Link 03/2024 - 09/2002
9	Morphine (MS Contin)FDA LinkGeneric 01/2021 - 09/2002
9	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2014 - 07/2006
9	Mitogen-Activated Protein KinasesIBA 12/2013 - 01/2002
8	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 10/2013 - 01/2002
7	Neurotransmitter Agents (Neurotransmitter)IBA 03/2024 - 08/2005
7	Neutralizing AntibodiesIBA 03/2024 - 07/2007
7	Ion Channels (Ion Channel)IBA 12/2021 - 09/2002
7	Peptides (Polypeptides)IBA 01/2018 - 03/2006
7	Freund's AdjuvantIBA 01/2016 - 01/2002
6	Monoclonal AntibodiesIBA 08/2021 - 01/2014
6	protectin D1IBA 01/2021 - 10/2011
6	D-JNKI-1IBA 02/2018 - 03/2006
6	Phosphotransferases (Kinase)IBA 01/2018 - 09/2004
6	Small Interfering RNA (siRNA)IBA 02/2016 - 11/2010
6	JNK Mitogen-Activated Protein KinasesIBA 11/2010 - 03/2006
5	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2023 - 05/2010
5	Interleukin-6 (Interleukin 6)IBA 01/2023 - 05/2008
5	resolvin D1IBA 01/2021 - 09/2011
5	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2020 - 04/2012
5	Peptide Hydrolases (Proteases)FDA Link 01/2020 - 12/2013
5	Interleukin-1beta (Interleukin 1 beta)IBA 03/2012 - 07/2006
4	Minocycline (Cyclops)FDA LinkGeneric 03/2024 - 11/2012
4	Interferon Type IIBA 01/2024 - 01/2021
4	Matrix Metalloproteinases (MMPs)IBA 01/2019 - 03/2008
4	Voltage-Gated Sodium ChannelsIBA 02/2018 - 04/2002
4	Messenger RNA (mRNA)IBA 04/2016 - 09/2002
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2016 - 09/2004
4	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 11/2014 - 09/2003
4	Glutamic Acid (Glutamate)FDA Link 12/2013 - 09/2002
4	5S,12R,18R- trihydroxy- 6Z,8E,10E,14Z,16E- eicosapentaenoic acidIBA 03/2013 - 05/2010
3	7,14- dihydroxydocosa- 4,8,10,12,16,19- hexaenoic acidIBA 03/2024 - 04/2012
3	Potassium Channels (Potassium Channel)IBA 03/2024 - 08/2013
3	MicroRNAs (MicroRNA)IBA 03/2024 - 04/2014
3	Nerve Growth Factor (NGF)IBA 03/2024 - 09/2002
3	InterferonsIBA 01/2024 - 01/2021
3	LipopolysaccharidesIBA 01/2023 - 01/2018
3	Glial Fibrillary Acidic ProteinIBA 12/2022 - 11/2012
3	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 12/2020 - 08/2007
3	mu Opioid Receptors (mu Opioid Receptor)IBA 01/2020 - 09/2005
3	NeuropeptidesIBA 01/2019 - 10/2007
3	Docosahexaenoic AcidsIBA 01/2018 - 11/2011
3	InterleukinsIBA 01/2017 - 10/2010
3	N-Methylaspartate (NMDA)IBA 01/2016 - 08/2005
3	TRPV Cation ChannelsIBA 10/2007 - 09/2004
2	LigandsIBA 03/2024 - 01/2021
2	Streptozocin (Streptozotocin)FDA Link 12/2023 - 01/2021
2	DinitrofluorobenzeneIBA 01/2023 - 01/2021
2	Gabapentin (Neurontin)FDA LinkGeneric 01/2023 - 12/2015
2	Janus KinasesIBA 01/2022 - 04/2011
2	Programmed Cell Death 1 ReceptorIBA 08/2021 - 07/2017
2	NivolumabIBA 01/2021 - 01/2020
2	Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA 01/2021 - 09/2005
2	Interleukin-23 (Interleukin 23)IBA 01/2021 - 01/2021
2	Cytostatic AgentsIBA 12/2020 - 11/2016
2	Histamine (Histamine Dihydrochloride)FDA Link 01/2020 - 11/2010

Therapy/Procedure

32	Spinal Injections 03/2024 - 01/2002
22	Therapeutics 01/2023 - 09/2002
13	Drug Therapy (Chemotherapy) 12/2023 - 04/2012
13	Ligation 02/2016 - 05/2003
9	Analgesia 01/2023 - 03/2012
5	Immunotherapy 10/2023 - 01/2020
3	Immunomodulation 10/2023 - 01/2020
3	Spinal Cord Stimulation 01/2021 - 07/2015